Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

Item
http://www.wikidata.org/entity/Q37202085
Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillanceProstate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study.Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.PSA Velocity and Doubling Time in Diagnosis and Prognosis of Prostate Cancer.Personalized management in low-risk prostate cancer: the role of biomarkers.Role of active surveillance in the management of localized prostate cancer.Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study.Biomarkers for prostate cancer: present challenges and future opportunities.Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails.Transurethral resection of the prostate for patients with Gleason score 6 prostate cancer and symptomatic prostatic enlargement: a risk-adaptive strategy for the era of active surveillance.Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancerProstate cancer screening: Canadian guidelines 2011Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohorts.Insulin-like growth factors (IGFs) and IGF-binding proteins in active monitoring of localized prostate cancer: a population-based observational study.PET/CT with (18)F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?
P2860

Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

Item
http://www.wikidata.org/entity/Q37202085
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostate-specific antigen kine ...... rly prostate cancer--a review.
@en
Prostate-specific antigen kine ...... rly prostate cancer--a review.
@nl
type
label
Prostate-specific antigen kine ...... rly prostate cancer--a review.
@en
Prostate-specific antigen kine ...... rly prostate cancer--a review.
@nl
prefLabel
Prostate-specific antigen kine ...... rly prostate cancer--a review.
@en
Prostate-specific antigen kine ...... rly prostate cancer--a review.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Prostate-specific antigen kine ...... arly prostate cancer--a review
@en
P2093
P304
P31
P356
10.1016/J.EURURO.2008.06.040
P407
P433
P478
P50
P577
P698